What's Ahead for SARS-CoV-2 Research in 2021
The Scientist - January 08, 2021
Kartik Chandran, Ph.D., talks about the future of COVID-19 research, including the development of treatments and vaccines to treat and prevent the novel coronavirus as it mutates over time. Dr. Chandran is professor of microbiology & immunology and the Harold and Muriel Block Scholar in Virology at Einstein.
The Coronavirus is Mutating. What Does That Mean for Us?
The New York Times - December 20, 2020
Kartik Chandran, Ph.D., comments on a highly contagious new variant of the coronavirus, noting the body produces numerous antibodies that will make it difficult for the virus to escape a full immune system response. Dr.Chandran is professor of microbiology & immunology and the Harold and Muriel Block Scholar in Virology at Einstein.
Additional Coverage includes The Scientist
The Race for a Super-Antibody Against the Coronavirus
The New York Times - October 12, 2020
Kartik Chandran, Ph.D., describes the efforts of a multi-institutional collaboration he is leading to discover a potent, long-lasting antibody that would be effective against a range of coronaviruses, not only the one that causes COVID-19. Dr. Chandran is professor of microbiology & immunology and the Harold and Muriel Block Scholar in Virology at Einstein.
First Ebola Treatment Approved by FDA
Chemical & Engineering News - October 11, 2020
Kartik Chandran, Ph.D., comments on the importance of developing antibody treatments for Ebola and other emerging viruses. Dr. Chandran is professor of microbiology & immunology and the Harold and Muriel Block Scholar in Virology at Einstein.
October 11, 2020
Wall Street Journal interviews Kartik Chandran, Ph.D., and Steven Walkley, D.V.M., Ph.D., about the connection between the rare genetic disease Niemann-Pick Type C (NPC) and Ebola. Dr. Chandran’s research suggests that the gene mutation responsible for NPC may offer protection against Ebola. Dr. Walkley notes that it is well-known that carriers of certain genetic diseases might have protection against other diseases, citing that carriers for sickle-cell disease might be protected against malaria. Dr. Chandran is associate professor of microbiology & immunology and holds the Harold and Muriel Block Faculty Scholar in Virology. Dr. Walkley is director of the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center and professor of pathology, of neurology and of neuroscience at Einstein. (subscription only)
More coverage on this story
The Scientist
CBSNews.com
November 3, 2014
The New York Daily News interviews Kartik Chandran, Ph.D., about the evolving Ebola epidemic and the risk of airline travel in light of news that someone who later tested positive for the virus traveled by air while infected. Dr. Chandran notes that there has never been a case when a person caught Ebola on an airplane. Dr. Chandran is associate professor of microbiology & immunology and holds the Harold and Muriel Block Faculty Scholar in Virology.
October 16, 2014
New York Times interviews Kartik Chandran, Ph.D., about new research that found the experimental Ebola drug ZMapp was successful in treating monkeys infected with the virus. The drug was used to treat two American aid workers infected during the current West African outbreak. Dr. Chandran notes the preliminary results were astounding as following treatment all the monkeys were healthy. Dr. Chandran is associate professor of microbiology & immunology and holds the Harold and Muriel Block Faculty Scholar in Virology
September 2, 2014
Huffington Post featured an op-ed co-written by Kartik Chandran, Ph.D., that addresses why no drug has been developed to cure Ebola. Dr. Chandran and co-author John Dye, Ph.D., of the United States Army Medical Research Institute of Infectious Diseases, note that industry might be hesitant to invest in research for a drug that treats a virus infecting a relatively small number of people. They also call for innovative academia-industry partnerships. Dr. Chandran is associate professor of microbiology & immunology and holds the Harold and Muriel Block Faculty Scholar in Virology.
July 10, 2014
The Science Channel’s “Through The Wormhole” interviews Kartik Chandran, Ph.D., about how the deadly Ebola virus infects humans. Dr. Chandran notes that viruses like Ebola have evolved to exploit access ways into cells, likening the behavior to using a lock pick to break into a padlock. Dr. Chandran is associate professor of microbiology & immunology and holds the Harold and Muriel Block Faculty Scholar in Virology.
June 30, 2014
National Geographic interviews Kartik Chandran, Ph.D., about the scientific possibility that a zombie-inducing virus, of the type featured in the film World War Z, could emerge in real life. Dr. Chandran provides some perspective on natural hybridization and spontaneous mutations that could lead to a novel and deadly virus spreading quickly, but notes that the majority of viruses on Earth actually infect single-celled microbes, not humans. Dr. Chandran is associate professor of microbiology & immunology.
June 25, 2013